Opioid Epidemic
News
Advancing Evidence-Based Substance Use Disorder Treatment Policies
Penn LDI/CHERISH Conference Explores State Licensure Trends in Medications for Opioid Use Disorder
Opioid Epidemic
Finding sustainable, humane, and effective solutions to the opioid epidemic.
Print:
Opioid Epidemic
Blog Post
What Can Pennsylvania Learn from the Opioid Epidemic?
Penn LDI Senior Fellow and Emergency Medicine Physician Testifies at House Health Committee Hearing
Opioid Epidemic
Blog Post
Providing Naloxone in the Emergency Department Can Save Lives
At-Risk Patients who Received Education Plus Naloxone in the Emergency Department Reported Increased Likelihood of Carrying it
Anish Agarwal, MD, MPH
- Assistant Professor, Emergency Medicine, Perelman School of Medicine
Nancy Aitcheson, MD, MSHP
- Assistant Professor, Infectious Disease, Perelman School of Medicine
Zarina Ali, MD
- Assistant Professor, Neurosurgery, Perelman School of Medicine
Abby Alpert, PhD
- Assistant Professor, Health Care Management, Wharton School
Shoshana Aronowitz, PhD, MSHP
- Assistant Professor, Family and Community Health, Penn Nursing
Michael Ashburn, MD, MPH
- Professor, Anesthesiology and Critical Care, Perelman School of Medicine
Chethan Bachireddy, MD, MSc
- Chief Medical Officer, Department of Medical Assistance Services, Virginia
Wade Berrettini, MD, PhD
- Karl E. Rickels Professor, Psychiatry, Perelman School of Medicine
Opioid Epidemic Working Group
Penn LDI is collaborating with researchers and policymakers throughout the country to identify evidence-based, sustainable, and effective solutions to combat the nation’s unprecedented opioid epidemic. LDI Senior Fellows and staff regularly produce research and policy briefs, blogs, and publications, as well as convene key stakeholders with the goal of addressing treatment, harm reduction, and the social determinants of health that are driving the opioid epidemic.
Research Updates
Fentanyl Remains the Big Driver of Overdoses so Stay Focused on Naloxone as an Antidote
LDI’s Jeanmarie Perrone Names Biggest Takeaways from NIDA’s Conference on Opioid Care
Many State Medicaid Programs Still Require Prior Authorization for Buprenorphine Treatment for Opioid Use Disorder
Removing Barriers Could Improve Patient Outcomes
LDI Experts Analyze the New U.S. Plan to Target Xylazine-Laced Fentanyl
Some Doubt That It Goes Far Enough
Feds Severely Restricted Methadone Doses at Home for Opioid Addiction for Years
What Happened When SAMSHA, an Agency of the Federal Government, Relaxed This Restriction Because of COVID-19?
Dear Future Mayor: In The Fight Against Opioids, Be Bold
We Can Understand Why The Prospect of an Overdose Prevention Site, Also Known as a Supervised or Safe Injection Site, Gives Some Elected Officials Pause. But Hear Us Out.
Patients With Opioid Addiction Describe the Factors That Make Them Quit Methadone
Q&A With Dr. Ashish Thakrar Reveals Policy Gaps and How the System Could Be Improved
Vending Machines Are Dispensing Hope and Health in Philadelphia’s Opioid Crisis
They Deliver Drugs and Tools to Fight the Epidemic; Community Members Suggest Strategies for How They Can Gain Acceptance
Will States and Counties Spend Their National Opioid Settlements Effectively?
A Penn LDI Virtual Seminar Focuses on How $54 Billion Could Impact the Current Opioid Crisis